OSE Immunotherapeutics SA (ORPOF) Stock Overview
Explore OSE Immunotherapeutics SA’s financial performance, market position, analyst ratings, and future outlook.
OSE Immunotherapeutics SA (ORPOF)
Key Financials
Key Financials
Market Cap
100.3M
P/E Ratio
N/A
EPS (TTM)
$-0.98
ROE
N/A
ORPOF Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of OSE Immunotherapeutics SA (ORPOF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 0.00, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $11.60.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of N/A and a market capitalization of 100.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.